Overview
At Mira Health Solutions, we are pioneering a transformative approach in the biotech industry by creating tailored medication solutions that cater to individual genetic profiles. Our flagship product leverages advanced biotechnological methods to design personalized medications that significantly improve patient outcomes. After launching our initial prototype in early 2025, we've gathered feedback from over 1,000 users, confirming the efficacy and demand for our innovative solution. Our team consists of leading experts from the fields of genomics, pharmacology, and data analysis, ensuring a robust foundation for our product development. In just 18 months, we've achieved vital milestones, including successfully completing preliminary clinical trials and forging partnerships with key healthcare institutions. However, to fully realize our vision and meet the increasing demand for personalized medicine, we require further investment to scale our operations, conduct larger clinical studies, and refine our product offerings. This investment will not only expedite our go-to-market strategy but also solidify our position within the competitive biotech sector. we are preparing to scale this…
Use of funds
The requested $1,500,000 will be allocated as follows:
- Research and Development: $600,000 for further refining our medication formulations and conducting extensive clinical trials.
- Operational Costs: $400,000 for scaling production capabilities and hiring additional staff in R&D and marketing.
- Regulatory Compliance: $300,000 to navigate the necessary regulatory pathways for FDA approval and other certifications.
- Marketing and Outreach: $200,000 to establish partnerships with healthcare providers and increase brand awareness.
- Contingency Fund: $100,000 for unexpected expenses during the execution of our plans.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.